Mark Hopman
Insider Reports History
- Location
- Irvine, CA
- Signature
- /s/ Stephen Feider, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Mark Hopman:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Beta Bionics, Inc. | Chief Commercial Officer | Common Stock | 136,216 | $4,176,518 | $30.66 | 04 Dec 2025 | Direct |
| Beta Bionics, Inc. | Chief Commercial Officer | Employee Stock Option (right to buy) | 91,520 | 27 Feb 2026 | Direct |
Insider Reports Filed by Mark Hopman
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BBNX | Beta Bionics, Inc. | 04 Mar 2026 | 1 | -$4,084 | 4 | Chief Commercial Officer | 05 Mar 2026, 19:30 |
| BBNX | Beta Bionics, Inc. | 27 Feb 2026 | 1 | $0 | 4/A | Chief Commercial Officer | 13 Mar 2026, 16:15 |
| BBNX | Beta Bionics, Inc. | 02 Dec 2025 | 2 | -$88,304 | 4 | Chief Commercial Officer | 16 Mar 2026, 19:55 |
| BBNX | Beta Bionics, Inc. | 04 Sep 2025 | 8 | -$288,421 | 4 | Chief Commercial Officer | 08 Sep 2025, 18:15 |
| BBNX | Beta Bionics, Inc. | 02 Sep 2025 | 1 | -$15,996 | 4 | Chief Commercial Officer | 04 Sep 2025, 18:45 |
| BBNX | Beta Bionics, Inc. | 19 Aug 2025 | 3 | -$185,971 | 4 | Chief Commercial Officer | 20 Aug 2025, 21:30 |
| BBNX | Beta Bionics, Inc. | 02 Jun 2025 | 3 | -$15,529 | 4 | Chief Commercial Officer | 04 Jun 2025, 19:30 |
| BBNX | Beta Bionics, Inc. | 27 Feb 2025 | 2 | $0 | 4 | Chief Commercial Officer | 03 Mar 2025, 17:45 |
| BBNX | Beta Bionics, Inc. | 31 Jan 2025 | 5 | $0 | 4 | Chief Commercial Officer | 03 Feb 2025, 20:30 |
| BBNX | Beta Bionics, Inc. | 29 Jan 2025 | 1 | $0 | 4 | Chief Commercial Officer | 31 Jan 2025, 16:31 |
| BBNX | Beta Bionics, Inc. | 29 Jan 2025 | 0 | $0 | 3 | Chief Commercial Officer | 29 Jan 2025, 21:43 |